Challenges in Tissue Engineering and Regenerative Medicine Product Commercialization: Building an Industry

被引：0

作者：

Hellman, Kiki B. ^{[1
]}

Johnson, Peter C. ^{[2
,3
]}

Bertram, Timothy A. ^{[4
]}

Tawil, Bill ^{[5
,6
]}

机构：

[1] Hellman Grp LLC, Clarksburg, MD USA

[2] Avery Dennison Med Prod Div, Raleigh, NC USA

[3] Scintellix LLC, Raleigh, NC USA

[4] Tengion Inc, Sci & Technol, Winston Salem, NC USA

[5] Global Expans, Baxter Biosurg, Westlake Village, CA USA

[6] Univ Calif Los Angeles, Dept Bioengn, Los Angeles, CA USA

来源：

TISSUE ENGINEERING PART A | 2011年 / 17卷 / 1-2期

关键词：

D O I：

10.1089/ten.tea.2010.0436

中图分类号：

Q813 [细胞工程];

学科分类号：

摘要：

引用

页码：1 / 3

页数：3

共 50 条

[1] Hurdles in Tissue Engineering/Regenerative Medicine Product Commercialization: A Survey of North American Academia and Industry
Johnson, Peter C.
Bertram, Timothy A.
Tawil, Bill
Hellman, Kiki B.
[J]. TISSUE ENGINEERING PART A, 2011, 17 (1-2) : 5 - 15
[2] Hurdles in Tissue Engineering/Regenerative Medicine Product Commercialization: A Pilot Survey of Governmental Funding Agencies and the Financial Industry
Bertram, Timothy A.
Tentoff, Edward
Johnson, Peter C.
Tawil, Bill
Van Dyke, Mark
Hellman, Kiki B.
[J]. TISSUE ENGINEERING PART A, 2012, 18 (21-22) : 2187 - 2194
[3] Enhancing Tissue Engineering/Regenerative Medical Product Commercialization: The Role of Science in Regulatory Decision Making for Tissue Engineering/Regenerative Medicine Product Development
Bertram, Timothy A.
Johnson, Peter C.
Tawil, Bill
Van Dyke, Mark
Hellman, Kiki B.
[J]. TISSUE ENGINEERING PART A, 2013, 19 (21-22) : 2313 - 2313
[4] Perspectives and Challenges in Tissue Engineering and Regenerative Medicine
Langer, Robert
[J]. ADVANCED MATERIALS, 2009, 21 (32-33) : 3235 - 3236
[5] Editorial: Industrialization and commercialization in tissue engineering and regenerative medicine: 2022/2023
Siow, Kim S.
Shi, Wen
Akhavan, Behnam
[J]. FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY, 2024, 12
[6] Enhancing Tissue Engineering/Regenerative Medical Product Commercialization: The Role of Science in Regulatory Decision Making for Tissue Engineering/Regenerative Medicine Product Development (vol 19, pg 2313, 2013)
Bertram
Hellman, Kiki B.
[J]. TISSUE ENGINEERING PART A, 2013, 19 (23-24) : 2735 - 2735
[7] The challenges of product development and commercialization in a convergence technology world: focus on regenerative medicine
Tozer, Dean
[J]. DRUG DISCOVERY TODAY, 2010, 15 (15-16) : 587 - 589
[8] Tissue Engineering and Regenerative Medicine: History, Progress, and Challenges
Berthiaume, Francois
Maguire, Timothy J.
Yarmush, Martin L.
[J]. ANNUAL REVIEW OF CHEMICAL AND BIOMOLECULAR ENGINEERING, VOL 2, 2011, 2 : 403 - 430
[9] Tissue Engineering and Regenerative Medicine: The Promise, the Challenges, the Future
Mertz, Leslie
[J]. IEEE PULSE, 2017, 8 (03) : 15 - 18
[10] Enhancing Tissue Engineering and Regenerative Medicine Product Commercialization: The Role of Science in Regulatory Decision-Making for the TE/RM Product Development
Bertram, Timothy A.
Johnson, Peter C.
Tawil, Bill J.
Van Dyke, Mark
Hellman, Kiki B.
[J]. TISSUE ENGINEERING PART A, 2015, 21 (19-20) : 2476 - 2479

← 1 2 3 4 5 →